Ciprofibrate

DB09064ApprovedInvestigationalWithdrawnSmall molecule

Ciprofibrate: Overview.

Chemical structure of Ciprofibrate
Mechanism
Curator reviewed
Formula / weight
C13H14Cl2O3 · 289.15 g/mol (avg)
Code names
WIN-35833

Resolves to

Compound
UNIIF8252JGO9SCAS52214-84-3ChEMBLCHEMBL557555ChEBI50867KEGGD03521
Clinical / RWD
RxNorm21149ATCC10AB08
Structure
InChIKeyKPSRODZRAIWAKH-UHFFFAOYSA-NSMILESCC(C)(OC1=CC=C(C=C1)C1CC1(Cl)Cl)C(O)=O
Targets
Q07869PPARA

What you can answer from here — as of March 19, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
157Drug interactionsStructured to mechanism, not free text
Sign in
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
19Marketed productsAcross 4 countries and 12 labellers
Sign in
1ATC codeIncluding every combination product, plus 17 drug categories
Sign in
9+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Ciprofibrate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In